Skip to main content

What the FDA labels say about taking them together

Dasiglucagon and indomethacin

Dasiglucagon's FDA label of January 1, 2023 names indomethacin in its drug interactions section; the indomethacin labels PlainMeds reads (4) do not name dasiglucagon. The dasiglucagon label: “In patients taking indomethacin, ZEGALOGUE may lose its ability to raise blood glucose or may even produce hypoglycemia.”

Check it at the source: the dasiglucagon FDA label on DailyMed (effective January 1, 2023, Novo Nordisk); the indomethacin FDA label on DailyMed (effective December 19, 2025, Glenmark Pharmaceuticals Inc., USA).

What does the dasiglucagon label say about indomethacin?

Dasiglucagon label, drug interactions

Clinical Impact: In patients taking indomethacin, ZEGALOGUE may lose its ability to raise blood glucose or may even produce hypoglycemia.

Source: FDA drug label (Zegalogue), NDA214231 (Zealand Pharma), as published by Novo Nordisk, effective January 1, 2023 (SPL set 14704879-872c-4967-8779-04a3bbdfb4e6), via openFDA; the full label on DailyMed

What does the indomethacin label say about dasiglucagon?

Indomethacin's label (effective December 19, 2025) and its 3 other brand-application labels do not name dasiglucagon in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Indomethacin), Glenmark Pharmaceuticals Inc., USA, effective December 19, 2025 (SPL set f7ed39e2-5431-4e47-935c-c7441d058f94), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Dasiglucagon generic labelers
31Indomethacin generic labelers
DasiglucagonIndomethacin
Labeled forn/aRheumatoid arthritis, Osteoarthritis
Boxed warningNoYes
Pharmacy cost (NADAC)$493.36 per mL 0.6 mg/0.6 mL autoinj$0.210 per capsule 75 mg capsule
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?